Table 3 Factors associated with the rate of statin non-adherence (n =12,100)

Inflammatory rheumatic disease

1.11

0.82, 1.52

0.49

Age group, years

<50

1

-

-

50 to 59

0.80

0.72, 0.89

<0.001

60 to 69

0.67

0.59, 0.75

<0.001

70 to 79

0.58

0.51, 0.66

<0.001

80+

0.49

0.42, 0.58

<0.001

Female

0.97

0.89, 1.06

0.49

Indigenous

2.01

1.69, 2.41

<0.001

Married/de-facto

0.91

0.84, 0.99

0.03

Remote¹

1.02

0.86, 1.22

0.86

Lowest quartile of Socio-Economic Indexes for Areas Index of Relative Socio-Economic Disadvantage (SEIFA-IRSD)

1.12

0.97, 1.30

0.12

Elective admission

0.87

0.75, 1.01

0.06

Intensive Care Unit during admission

0.98

0.87, 1.09

0.65

Hospital type

Tertiary

1

-

-

Public metro

0.92

0.65, 1.31

0.64

Rural public/private

0.88

0.77, 0.99

0.04

Private metro

1.00

0.89, 1.13

0.94

Comorbidities at index admission²

Cancer

1.09

0.77, 1.53

0.63

Cerebral vascular accident

0.80

0.58, 1.09

0.16

Dementia

1.04

0.60, 1.81

0.88

Diabetes

1.02

0.91, 1.14

0.72

HIV

-

-

-

Liver disease

1.51

0.63, 3.63

0.36

Paraplegia

0.92

0.56, 1.53

0.76

Peptic ulcer

1.29

0.86, 1.94

0.21

Pulmonary disease

1.06

0.87, 1.29

0.57

Peripheral vascular disease

1.02

0.78, 1.35

0.87

Renal Disease

1.00

0.84, 1.19

0.96

Cardiovascular Risk factors

Smoker

1.17

1.07, 1.27

<0.001

Hypertension

1.06

0.98, 1.14

0.15

Hypercholesterolaemia

1.03

0.95, 1.11

0.54

Obesity

1.15

1.01, 1.30

0.03

Count of PBS medications at 3 months post MI

0 to 1

1

-

-

2 to 5

0.76

0.60, 0.96

0.02

6 to 10

0.70

0.55, 0.89

<0.01

>10

0.68

0.52, 0.87

<0.01

Statin use within 12 months prior to index MI

0.90

0.82, 0.98

0.02